Related Experiment Video
Updated: Aug 30, 2026

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Octreotide for enterocutaneous fistulas of Crohn's disease
Unlabelled:
Crohn's disease is a chronic, life-long disease and has many troublesome complications. Fistulas are a part of Crohn's disease, and although there are many therapeutic modalities used in treating these fistulas they are only partially successful. As we are still very far from being able to cure it, the aim is to improve the patients' quality of life and to reduce the iatrogenic harm that may be caused by various treatment modalities. Somatostatin is an inhibitor of intestinal secretion and has been used to treat pancreatic and surgical fistulas. Therefore, we decided to treat enterocutaneous fistulas using somatostatin.
Methods:
Five patients with Crohn's disease were treated with four daily injections of 300 microg octreotide. The total period of treatment was eight weeks.
Results:
Closure of fistulas was achieved in four of the five patients.
Conclusion:
Somatostatin may have a role in treating Crohn's disease enterocutaneous fistulas and may prevent surgery or prolonged immunosuppressive therapy.
Related Concept Videos
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Drugs for Treatment of Ulcerative Colitis in IBD
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...